Does PERTUZUMAB Cause Malignant neoplasm progression? 233 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 233 reports of Malignant neoplasm progression have been filed in association with PERTUZUMAB (PERJETA). This represents 1.1% of all adverse event reports for PERTUZUMAB.
233
Reports of Malignant neoplasm progression with PERTUZUMAB
1.1%
of all PERTUZUMAB reports
45
Deaths
54
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PERTUZUMAB?
Of the 233 reports, 45 (19.3%) resulted in death, 54 (23.2%) required hospitalization, and 3 (1.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 233 reports have been filed with the FAERS database.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PERTUZUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN